Literature DB >> 7506307

The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis.

M J Davies1, J L Gordon, A J Gearing, R Pigott, N Woolf, D Katz, A Kyriakopoulos.   

Abstract

The expression of PECAM, ICAM-1, VCAM-1, and E-selectin was studied in 64 samples of human coronary arteries taken from 15 explanted hearts obtained within 5 min of transplantation. Normal artery (n = 12), predominantly fibrous plaques (n = 23), and plaques containing extracellular lipid (n = 26) and three segments showing recanalization channels were studied. All endothelial cells strongly and equally expressed PECAM; positive staining was used to check that artefactual denudation of the endothelial surface had not occurred. PECAM was also present in some lipid-filled macrophages. Normal arteries showed no VCAM-1 staining but focal segments of the endothelium were positive for ICAM-1 and E-selectin. ICAM-1 was strongly and constantly expressed by the endothelium over all types of plaques and in macrophages. E-selectin expression was confined to endothelial cells and occurred on the surface in 35 per cent of fibrous and 22 per cent of lipid-containing plaques. VCAM-1 staining of surface endothelium occurred in 39 per cent of fibrous and 20 per cent of lipid-containing plaques. A population of spindle-shaped cells of macrophage type (positive for EMB11 antigen) expressed VCAM-1 in lipid-containing plaques. Adventitial vessels adjacent to plaques showed endothelial expression of ICAM-1 and E-selectin. VCAM-1 staining of adventitial vessel endothelium was associated with local lymphoid aggregation. In conclusion, the expression of cell adhesion molecules is an important element in the inflammatory component of atherosclerosis and contributes to both monocyte and lymphocyte activation and recruitment from adventitial vessels and the arterial lumen.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7506307     DOI: 10.1002/path.1711710311

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  133 in total

Review 1.  Antiinflammatory and immunomodulatory properties of statins.

Authors:  Ora Shovman; Yair Levy; Boris Gilburd; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 2.  Inflammation and lipid-lowering treatment.

Authors:  C M Ballantyne; Y Abe
Journal:  Curr Cardiol Rep       Date:  1999-09       Impact factor: 2.931

Review 3.  Magnetic resonance imaging of coronary atherosclerosis.

Authors:  Zahi A Fayad; Robin P Choudhury; Valentin Fuster
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

4.  Imaging of unstable atherosclerotic lesions.

Authors:  Jagat Narula; H William Strauss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-01       Impact factor: 9.236

5.  A multi-gene transcriptional profiling approach to the discovery of cell signature markers.

Authors:  Youichiro Wada; Dan Li; Anne Merley; Andrew Zukauskas; William C Aird; Harold F Dvorak; Shou-Ching Shih
Journal:  Cytotechnology       Date:  2010-10-23       Impact factor: 2.058

6.  Deletion of tenascin-C gene exacerbates atherosclerosis and induces intraplaque hemorrhage in Apo-E-deficient mice.

Authors:  Lai Wang; Wei Wang; Prediman K Shah; Lei Song; Mingjie Yang; Behrooz G Sharifi
Journal:  Cardiovasc Pathol       Date:  2012-02-01       Impact factor: 2.185

7.  Interleukin-4, Oxidative Stress, Vascular Inflammation and Atherosclerosis.

Authors:  Yong Woo Lee; Paul H Kim; Won Hee Lee; Anjali A Hirani
Journal:  Biomol Ther (Seoul)       Date:  2010-04       Impact factor: 4.634

Review 8.  Molecular imaging of atherosclerosis for improving diagnostic and therapeutic development.

Authors:  Thibaut Quillard; Peter Libby
Journal:  Circ Res       Date:  2012-07-06       Impact factor: 17.367

9.  Copper chelation by tetrathiomolybdate inhibits vascular inflammation and atherosclerotic lesion development in apolipoprotein E-deficient mice.

Authors:  Hao Wei; Wei-Jian Zhang; Timothy S McMillen; Renee C Leboeuf; Balz Frei
Journal:  Atherosclerosis       Date:  2012-06-16       Impact factor: 5.162

10.  Effect of preexisting statin use on expression of C-reactive protein, adhesion molecules, interleukin-6, and antioxidized low-density lipoprotein antibody in patients with unstable angina undergoing coronary stenting.

Authors:  Young-Cheoul Doo; Sang-Jin Han; Sung-Woo Han; Woo-Jung Park; Seung-Hyuk Choi; Goo-Yeong Cho; Kyung-Soon Hong; Kyoo-Rok Han; Nam-Ho Lee; Dong-Jin Oh; Kyu-Hyung Ryu; Chong-Yun Rim; Kwang-Hahk Lee; Yung Lee
Journal:  Clin Cardiol       Date:  2005-02       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.